Trial Profile
An open label, randomised, trial comparing efficacy and safety of high dose clopidogrel versus ticagrelor therapy in patients with acute coronary syndromes undergoing percutaneous coronary interventions
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Nov 2016
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Adverse reactions; Therapeutic Use
- 14 Nov 2016 New trial record